国产成人mv免费视频_无码精品毛片波多野吉衣_在线毛片äV网站免费观看_成人亚洲av电影_亚洲爆乳成av人在线网站_中国熟妇乱子hdsex粗_国产无遮挡污在线观看免费Aⅴ_日韩经典精品无码一区18_欧美巨大另类极品ⅴideosbest_午夜成人免费看在线观看
Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(華堂寧?)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
中
中
中
Our Science
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Product
HuaTangNing(華堂寧?)
Investor Relations
Investor Center
Corporate Governance
Financial Report
Announcements and Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock Information
Corporate Communications
Media
Company News
Media Releases
Video
About Us
Company Overview
Company History
Leadership Team
Partner
Portfolio Advisory Board
Senior Scientific Advisory Board
Media Center
Careers
Company Culture
Join Us
Contact Us
Our Science
>
Our Science
>
Pipeline
Science & Innovation
Pipeline
Dorzagliatin
mGluR5
Poster and Presentation
Peer Reviewed Publications
Pipeline
Product and Pipeline
Indication
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
Dorzagliatin
T2D - Drug Na?ve
T2D - Metformin Tolerated
RWE study for Diabetes Remission
Diabetes Prevention
Neurodegeneration
Dorzagliatin and Metformin FDC
T2D
Dorzagliatin + Empagliflozin
DKD
Dorzagliatin + Sitagliptin
T2D
Dorzagliatin add on to GLP1RA
T2D and Obesity
Dorzagliatin add on to Insulin
T1D
2nd Generation GKA
Metabolic Disease
mGLUR5 NAM
PD-LID
Drug Addiction
GK NAM
Metabolic Disease
Dorzagliatin
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
T2D - Drug Na?ve
T2D - Metformin Tolerated
RWE study for Diabetes Remission
Diabetes Prevention
Neurodegeneration
Dorzagliatin and Metformin FDC
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
T2D
Dorzagliatin + Empagliflozin
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
DKD
Dorzagliatin + Sitagliptin
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
T2D
Dorzagliatin add on to GLP1RA
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
T2D and Obesity
Dorzagliatin add on to Insulin
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
T1D
2nd Generation GKA
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
Metabolic Disease
mGLUR5 NAM
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
PD-LID
Drug Addiction
GK NAM
Discovery
(Pre-clinical-Phase II)
Development
(Phase III)
Commercialization
Metabolic Disease
About Us
Company Overview
Company History
Leadership Team
Portfolio Advisory Board
Senior Scientific Advisory Board
Partner
Media center
Research & Development
Inovation
Pipeline
Dorzagliatin
mGluR5
Company Publications
Peer Reviewed Publications
Investor Relations
Corporate Governance
Financial Report
Announcements & Circulars
Listing Documents
Investor Presentation
IR Contact
Investor Calendar
Stock information
Media
Company News
Media Releases
Video
Careers
Culture
Join Us
Product
HuaTangNing(華堂寧?)
Subscribe Email
Focus Us
Copyright ? 2024 Hua Medicine (Shanghai) Co., Ltd. 互聯(lián)網(wǎng)藥品信息服務(wù)資格證書(shū)編號(hào): (滬)-非經(jīng)營(yíng)-2022-0079
滬ICP備14036654號(hào)-1
滬公網(wǎng)安備 31011502013809號(hào)
Privacy Statement
Terms of Use
Search
How we use cookies
Hua Medicine uses cookies to enable and improve the use of the website. By continuing to use the site, you consent to the use of these cookies. To learn more about cookies, please read our
privacy statement
.
Accept
x